Miracle Mile Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.78M | Buy |
41,440
+4,115
| +11% | +$576K | 0.08% | 176 |
|
|
2025
Q4 | $4.58M | Buy |
37,325
+3,221
| +9% | +$391K | 0.07% | 201 |
|
|
2025
Q3 | $3.79M | Buy |
34,104
+25,117
| +279% | +$2.85M | 0.06% | 213 |
|
|
2025
Q2 | $996K | Buy |
8,987
+1,011
| +13% | +$108K | 0.02% | 366 |
|
|
2025
Q1 | $894K | Buy |
7,976
+1,407
| +21% | +$145K | 0.02% | 343 |
|
|
2024
Q4 | $607K | Sell |
6,569
-920
| -12% | -$82.8K | 0.01% | 409 |
|
|
2024
Q3 | $628K | Sell |
7,489
-356
| -5% | -$27.2K | 0.01% | 338 |
|
|
2024
Q2 | $538K | Buy |
7,845
+266
| +4% | +$17.8K | 0.01% | 337 |
|
|
2024
Q1 | $555K | Buy |
7,579
+255
| +3% | +$19.6K | 0.01% | 337 |
|
|
2023
Q4 | $593K | Sell |
7,324
-119
| -2% | -$9.26K | 0.02% | 318 |
|
|
2023
Q3 | $558K | Hold |
7,443
| – | – | 0.02% | 314 |
|
|
2023
Q2 | $574K | Sell |
7,443
-13
| -0.2% | -$1.04K | 0.02% | 328 |
|
|
2023
Q1 | $619K | Buy |
7,456
+530
| +8% | +$43.9K | 0.02% | 334 |
|
|
2022
Q4 | $595K | Sell |
6,926
-1,790
| -21% | -$142K | 0.02% | 333 |
|
|
2022
Q3 | $538K | Buy |
8,716
+1,825
| +26% | +$115K | 0.03% | 283 |
|
|
2022
Q2 | $426K | Sell |
6,891
-5,171
| -43% | -$320K | 0.02% | 319 |
|
|
2022
Q1 | $717K | Buy |
12,062
+1,190
| +11% | +$76.1K | 0.03% | 273 |
|
|
2021
Q4 | $789K | Buy |
10,872
+3,974
| +58% | +$274K | 0.03% | 256 |
|
|
2021
Q3 | $482K | Sell |
6,898
-16
| -0.2% | -$1.12K | 0.02% | 296 |
|
|
2021
Q2 | $476K | Hold |
6,914
| – | – | 0.03% | 265 |
|
|
2021
Q1 | $447K | Sell |
6,914
-210
| -3% | -$13.5K | 0.03% | 263 |
|
|
2020
Q4 | $415K | Sell |
7,124
-377
| -5% | -$22.7K | 0.03% | 268 |
|
|
2020
Q3 | $474K | Buy |
+7,501
| New | +$520K | 0.03% | 253 |
|
|
2020
Q2 | – | Sell |
-3,821
| Closed | -$286K | – | 318 |
|
|
2020
Q1 | $286K | Sell |
3,821
-3,867
| -50% | -$267K | 0.03% | 224 |
|
|
2019
Q4 | $500K | Sell |
7,688
-291
| -4% | -$18.9K | 0.03% | 194 |
|
|
2019
Q3 | $506K | Buy |
+7,979
| New | +$522K | 0.04% | 194 |
|
|
2018
Q4 | – | Sell |
-3,498
| Closed | -$270K | – | 158 |
|
|
2018
Q3 | $270K | Sell |
3,498
-9
| -0.3% | -$680 | 0.02% | 144 |
|
|
2018
Q2 | $248K | Sell |
3,507
-174
| -5% | -$12.3K | 0.02% | 141 |
|
|
2018
Q1 | $278K | Buy |
+3,681
| New | +$293K | 0.03% | 132 |
|
|
2017
Q1 | – | Sell |
-2,582
| Closed | -$2.88M | – | 87 |
|
|
2016
Q4 | $2.88M | Sell |
2,582
-382
| -13% | -$28.4K | 0.67% | 21 |
|
|
2016
Q3 | $235K | Buy |
2,964
+47
| +2% | +$3.82K | 0.06% | 72 |
|
|
2016
Q2 | $253K | Buy |
+2,917
| New | +$259K | 0.08% | 51 |
|
|
2016
Q1 | – | Sell |
-2,409
| Closed | -$244K | – | 58 |
|
|
2015
Q4 | $244K | Sell |
2,409
-332
| -12% | -$34.5K | 0.09% | 43 |
|
|
2015
Q3 | $269K | Buy |
+2,741
| New | +$304K | 0.09% | 45 |
|
Other funds holding GILD
VCM
VPM
Miracle Mile Advisors's GILD Position: Q1 2026 in Review
Miracle Mile Advisors increased its Gilead Sciences (GILD) stake by 11% in Q1 2026, buying an estimated $576K and bringing the position to 41,440 shares worth $5.78M. The position accounts for 0.08% of the portfolio, ranked #176.
Miracle Mile Advisors first reported a position in GILD in Q3 2015 and has held it in 34 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Miracle Mile Advisors held 41,440 shares of Gilead Sciences worth $5.78M as of Q1 2026.
- Miracle Mile Advisors bought 4,115 Gilead Sciences shares in Q1 2026, an estimated $576K.
- Gilead Sciences made up 0.08% of Miracle Mile Advisors's portfolio in Q1 2026, its #176 holding.
- Miracle Mile Advisors first reported a position in Gilead Sciences in Q3 2015 and has held it in 34 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Miracle Mile Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.